Published in Transplantation on June 01, 1993
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18
Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol (2008) 1.03
Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther (2009) 0.96
Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat. Gut (2007) 0.92
In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system--initial experience in mice. Eur Radiol (2007) 0.78
Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation (1997) 0.75
Slow persistent infection caused by visna virus: role of host restriction. Science (1977) 2.83
Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen (1996) 2.38
Adeno-associated virus as a vector for liver-directed gene therapy. J Virol (1998) 1.94
Is arthroscopic surgery for stabilisation of chronic shoulder instability as effective as open surgery? A systematic review and meta-analysis of 62 studies including 3044 arthroscopic operations. J Bone Joint Surg Br (2007) 1.91
Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun (1999) 1.87
Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science (1986) 1.61
Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry (1987) 1.60
Development of a hybrid bioartificial liver. Ann Surg (1993) 1.57
Epidural steroid injection for nerve root compression. A randomised, controlled trial. J Bone Joint Surg Br (2005) 1.43
Endurance training during a twin pregnancy in a marathon runner. Lancet (1998) 1.40
Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group. Cancer Invest (1997) 1.39
Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg (1997) 1.38
A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products. Cytotherapy (2008) 1.35
Compliance and use of the World Health Organization checklist in U.K. operating theatres. Br J Surg (2013) 1.31
Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun (2001) 1.31
Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res (1988) 1.29
The chicken HPRT gene: a counter selectable marker for the DT40 cell line. Nucleic Acids Res (1999) 1.27
Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology (1993) 1.23
Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol Suppl (1995) 1.21
Testing parameters in structural equation modeling: every "one" matters. Psychol Methods (2001) 1.20
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem (1999) 1.16
Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology (1988) 1.16
Fetal and utero-placental blood flow. Clin Obstet Gynaecol (1983) 1.15
A bioartificial liver to treat severe acute liver failure. Ann Surg (1994) 1.14
Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats. Hepatology (1988) 1.11
The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2000) 1.11
Hypoxic effects on exercise-induced diaphragmatic fatigue in normal healthy humans. J Appl Physiol (1985) (1995) 1.10
Morbidity and mortality reduction by supplemental vitamin A or beta-carotene in CBA mice given total-body gamma-radiation. J Natl Cancer Inst (1984) 1.05
Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation (1999) 1.04
Identification of pyruvate in S-adenosylmethionine decarboxylase from rat liver. J Biol Chem (1978) 1.01
Bioartificial liver support. J Hepatobiliary Pancreat Surg (2001) 1.01
Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J Surg Res (1999) 1.01
An intrachromosomal insertion causing 5q22 deletion and familial adenomatous polyposis coli in two generations. J Med Genet (1992) 1.00
Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg (1999) 0.99
Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats. Proc Natl Acad Sci U S A (1986) 0.99
Human liver cell transplantation. Prolonged function in athymic-Gunn and athymic-analbuminemic hybrid rats. Gastroenterology (1989) 0.99
The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor. Biotechnol Ther (1993) 0.97
Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer. Hum Gene Ther (1999) 0.97
Bone acidic glycoprotein-75 is a major synthetic product of osteoblastic cells and localized as 75- and/or 50-kDa forms in mineralized phases of bone and growth plate and in serum. J Biol Chem (1990) 0.97
Treatment of severe liver failure with a bioartificial liver. Ann N Y Acad Sci (1997) 0.95
Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation (1999) 0.95
Sensory innervation of the mammalian urethra. Invest Urol (1973) 0.95
Fetal rat hepatocytes: isolation, characterization, and transplantation in the Nagase analbuminemic rats. Transplantation (1997) 0.95
Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery (1993) 0.94
Hepatotrophic factors in liver growth and atrophy. Br J Exp Pathol (1985) 0.94
Intracranial pressure. Effects of pneumoperitoneum in a large-animal model. Surg Endosc (1997) 0.93
Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration. Hepatology (1996) 0.93
Biosynthesis of abscissic acid. Biochem Soc Trans (1983) 0.93
Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat. Gut (2007) 0.92
Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet (1993) 0.92
Automated liver cell processing facilitates large scale isolation and purification of porcine hepatocytes. ASAIO J (1995) 0.92
Pyrexia after total knee replacement. A cause for concern? Am J Orthop (Belle Mead NJ) (1997) 0.92
Enhanced proliferation and differentiation of rat hepatocytes cultured with bone marrow stromal cells. J Cell Physiol (2001) 0.91
Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa. J Rheumatol (1987) 0.91
Carboxyfluorescein (CFSE) labelling of hepatocytes for short-term localization following intraportal transplantation. Cell Transplant (1995) 0.91
In vivo selection of hepatocytes transduced with adeno-associated viral vectors. Mol Ther (2000) 0.91
Doppler blood flow waveforms in the descending thoracic aorta of the human fetus. Br J Obstet Gynaecol (1984) 0.91
Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Ann Clin Biochem (2000) 0.90
Lameness in feedlot cattle. Vet Clin North Am Food Anim Pract (2001) 0.90
Liver assist systems: state of the art. Int J Artif Organs (1998) 0.90
Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant (1995) 0.89
Incidental detection of haemoglobin (Hb) variants during high performance liquid chromatography (HPLC) analysis of HbA1c: is it time for a standardised approach to reporting? Ir J Med Sci (2014) 0.89
Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem (1997) 0.88
Techniques for intrasplenic hepatocyte transplantation in the large animal model. Surg Endosc (1996) 0.88
Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers. J Immunol (1984) 0.87
Loss and recovery of liver regeneration in rats with fulminant hepatic failure. J Surg Res (1997) 0.87
Structure-toxicity relationships of 2,6,7-trioxabicyclo(2.2.2)octanes and related compounds. Toxicol Appl Pharmacol (1976) 0.87
Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. J Clin Invest (2001) 0.86
Treatment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver. Transplant Proc (1997) 0.86
Fetal activity in 100 normal third trimester pregnancies. Br J Obstet Gynaecol (1980) 0.86
Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression. Arch Neurol (1988) 0.86
Vitamin A and retinoic acid: induced fibroblast differentiation in vitro. Surgery (1985) 0.86
Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure. Biochem Biophys Res Commun (2000) 0.85